glp 1 with ro Offers Eli Lilly's Foundayo™, the Newest GLP-1 Innovation Serena Williams Touts GLP-1 Health

Your prescriber can confirm this is appropriate for your situation, especially if you take other medications

In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%

Their dual benefits in glycaemic control and weight loss have made them an invaluable addition to the therapeutic landscape, yet their influence extends beyond clinical settings, impacting economic, cultural, and social realms (Wang et al., 2024)

20000839, Proteintech, China)